Site navigation
Make an Appointment
Other Quick Links
Donate

NASCAR STREET CLOSURES

Due to the NASCAR Chicago Street Race on July 5 - 6, and related events, there will be rolling street closures and traffic congestion June 19 - July 7.

Before your appointment, check the NASCAR website for the latest street closures. Bus routes may be affected. For current CTA and Metra schedules, visit TransitChicago and Metra. Navigation apps like Waze and Google Maps will reflect real-time closures

Please allow extra travel time. All hospital parking garages will remain open, though alternate routes may be needed.

Lurie Children’s Home Specialties & ConditionsFood Allergy Program Food Allergy Research

Food Allergy Research

Clinical Research Studies

Lurie Children’s Division of Allergy and Immunology is at the cutting edge of food allergy clinical research. We offer our patients with food allergy the newest treatments as well as opportunities to be part of studies in hopes to discover more treatments and a cure. 

We are currently recruiting patients in numerous food allergy studies. Learn more about our current trials:

ADORED

The ADORED study looks at whether once daily beneficial bacterial prevents the development of atopic illnesses in infants. The newborn should have an immediate family member (biological mother, biological father, and/or full sibling) with asthma, eczema, or any allergies. The ADORED study is no longer recruiting patients. 

Click here for the full study information or call 312.227.6474
Contact: AllergyStudy@luriechildrens.org

ALK Peanut SLIT Study; Phase-1

This study looks at the safety and tolerability of a new sublingual (under the tongue) tablet containing peanut allergen at different doses. The ALK Peanut SLIT Study study is no longer recruiting patients. 

Click here for the full study information
Contact: AllergyStudy@luriechildrens.org

Infants with Moderate-Severe Eczema and/or Egg Allergy and Peanut Allergy: Discovering a Significant Genotype 

This study of children 4-11 months with moderate to severe eczema or egg allergy looks to find biomarkers to help tell us whether or not a child will develop a peanut allergy and how severe a peanut allergy might be.

Click here for the full study information or call 312.227.5391

VITESSE Peanut Patch

This study will evaluate the safety, ease of use and efficacy of the investigational drug, Viaskin Peanut 250 mcg patch (DBV712). The study includes 12 study visits to Lurie Children’s and 5 study phone calls. Participants will receive payment for each completed study visit to compensate for time and travel. The VITESSE study is no longer recruiting patients. 

Click here for the full study information or call 312.227.6474
Contact: AllergyResearchNurse@luriechildrens.org 

Contact Us

For more information about our food allergy studies, please contact:

Email: allergystudy@luriechildrens.org​​

Basic Science and Public Health Research

The Center for Food Allergy and Asthma Research (CFAAR), part of the Institute for Public Health and Medicine (IPHAM) at Northwestern University Feinberg School of Medicine and Ann & Robert H. Lurie Children’s Hospital of Chicago, aims to find answers and shape policies surrounding food allergy, asthma and other allergic conditions.

Led by Ruchi Gupta, MD, MPH, CFAAR is comprised of three interdisciplinary and collaborative research cores: 1.) Public Health Data Repository Core, 2.) Clinical Research Core and 3.) Community/School Outreach Core. These cores are led by experts in the fields of epidemiology, health services research, health behavior, patient care, and advocacy seeking to make meaningful improvements in the health of children, adults, and families living with allergic disease.